Numata K, Murakami T, Oka M, Yamamoto H, Hatori M, Miyaki T, Oki T, Kawaguchi H
Bristol-Myers Research Institute, Ltd., Tokyo Research Center, Japan.
J Antibiot (Tokyo). 1988 Oct;41(10):1358-65. doi: 10.7164/antibiotics.41.1358.
Polyangium brachysporum sp. nov. strain ATCC 53080 produces a novel type of antifungal and antitumor antibiotic complex, glidobactins A, B and C. Enhanced production of minor components, glidobactins B and C, was achieved by medium modification. The addition of soybean oil or corn oil, which are rich in unsaturated C18 fatty acids, to the fermentation medium led to an increased production of components B and C. Productivity of component C was selectively enhanced by the addition of oleic acid-rich oils, olive oil and Tween 80 (polyoxyethylene sorbitan mono-oleate). Furthermore, precursing palmitoleate, linoleate and oleate permitted the direct biosynthesis of components A, B and C, respectively. The fermentation with 3% addition of an appropriate oil at initial time provided an optimal production of component B or C.
短孢多囊菌新种菌株ATCC 53080产生一种新型抗真菌和抗肿瘤抗生素复合物,即格利多菌素A、B和C。通过培养基改良实现了次要成分格利多菌素B和C产量的提高。向发酵培养基中添加富含不饱和C18脂肪酸的大豆油或玉米油,导致成分B和C的产量增加。添加富含油酸的油、橄榄油和吐温80(聚氧乙烯山梨醇单油酸酯)可选择性提高成分C的生产率。此外,棕榈油酸、亚油酸和油酸前体分别允许成分A、B和C的直接生物合成。在初始阶段添加3%的合适油进行发酵可实现成分B或C的最佳产量。